#USA #San Antonio #medical technology #Dräger #respiratory devices

Dräger Honored with Frost & Sullivan's 2025 Global Company of the Year Award

Dräger, a prominent player in the respiratory devices industry, has recently been acknowledged by Frost & Sullivan, receiving the prestigious title of Global Company of the Year for 2025. This accolade highlights Dräger's significant contributions to the field of respiratory care, underlining its innovative technologies designed to enhance patient outcomes and streamline clinical workflows.

Excellence in Innovation and Impact

The recognition comes as a result of Frost & Sullivan's meticulous evaluation process, which assesses companies based on visionary innovation and customer impact. Dräger has emerged as a frontrunner by aligning its innovation strategies with market demands. The company's focus on user-friendly designs addresses various healthcare needs, including scalability, flexibility, and cost-efficiency, ultimately improving the experience for both patients and healthcare providers.

Utkarsha Soundankar, an industry analyst at Frost & Sullivan, noted that Dräger’s product designs aim to decrease infection rates, readmission frequencies, and overall operational costs while enhancing patient comfort and care quality. This holistic approach is critical, especially in intensive care settings where precision and reliability are paramount.

Focus on Long-Term Growth

Dräger’s strategic vision emphasizes digital innovation, clinical partnerships, and the provision of value-based care. Their consistent investments in smart ventilator technologies and clinician training are paving the way for improved healthcare solutions worldwide. By prioritizing both advanced technology and training, Dräger establishes a robust framework that healthcare systems can depend on now and in the future.

Cutting-Edge Ventilatory Solutions

Central to Dräger’s innovations are its V-Series ventilators, which incorporate features such as SmartCare/PS and integrated capnography. These products are specifically crafted to shorten mechanical ventilation durations while aligning with bundled payment models that aim for budget-conscious care delivery. Furthermore, Dräger has also achieved significant milestones with its Evita V800/V600, Babylog VN800, and Savina 300 ventilators, earning authority to operate from the U.S. Department of Defense, thus enhancing medical device security and interoperability.

Redefining the Respiratory Care Ecosystem

Dräger is not only innovating in product development but is also revolutionizing the respiratory care ecosystem through comprehensive services. Its initiatives include maintenance programs and digital education platforms tailored for healthcare professionals. The launch of Dräger Virtuo, an immersive virtual reality training platform for Intensive Care Units (ICUs) and operating rooms, exemplifies the company's commitment to innovative training solutions that equip medical staff with essential skills.

Commitment to Excellence

By delivering over 84,500 hours of Continuing Respiratory Care Education (CRCE) credits annually, Dräger Academy ensures that clinicians stay updated with evolving practices, thus enhancing their confidence and effectiveness in high-pressure environments. This integrated educational model is particularly vital for quick onboarding and knowledge retention, elevating the standard of care that patients receive.

Frost & Sullivan commended Dräger’s strategic execution and ability to adapt its innovations to address the changing needs of the healthcare landscape. The company’s combined focus on top-tier technology, secure deployment, and professional development is setting a new benchmark in respiratory care excellence.

Conclusion

As Dräger continues to innovate and respond to the dynamic needs of the respiratory care community, its recognition as Frost & Sullivan's 2025 Global Company of the Year serves as a testament to its relentless pursuit of improving patient care and clinical outcomes. Dräger's unwavering dedication to delivering exceptional value, along with its expansive reach across more than 190 countries, underscores its position as a leader in medical and safety technology. With a mission to protect, support, and save lives, Dräger remains committed to advancing the future of respiratory care.

For further information about Dräger's initiatives and awards, please visit www.draeger.com.